Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Joella Ho"'
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 17, Iss 1, Pp 1-10 (2021)
Abstract Background Subcutaneous immunotherapy (SCIT) is an effective treatment for allergic rhinoconjunctivitis. However, adverse events, including life-threatening systemic reactions, may occur. The purpose of this project is to identify risk facto
Externí odkaz:
https://doaj.org/article/11095148fa0149d1b576bf487e347e6a
Autor:
Ritesh P. Daya, Jayant Bhandari, Sharnpreet K. Kooner, Joella Ho, Christopher D. Rowley, Nicholas A. Bock, Troy Farncombe, Ram K. Mishra
Publikováno v:
Frontiers in Behavioral Neuroscience, Vol 12 (2018)
PAOPA, a potent analog of prolyl-leucyl-glycinamide, has shown therapeutic potential at the preclinical stage for dopaminergic related illnesses, including animal models of schizophrenia, Parkinson’s disease and haloperidol-induced extrapyramidal m
Externí odkaz:
https://doaj.org/article/35e1aeacea904b069f84bd70655ba3fc
Publikováno v:
Current Molecular Pharmacology. 14:469-476
Background: Allosteric modulators of G-protein coupled receptors regulate receptor activity by binding to sites other than the active site and have emerged as a new and highly desirable class of drugs. PAOPA (3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-2
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 17, Iss 1, Pp 1-10 (2021)
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Background Subcutaneous immunotherapy (SCIT) is an effective treatment for allergic rhinoconjunctivitis. However, adverse events, including life-threatening systemic reactions, may occur. The purpose of this project is to identify risk factors for sy
Publikováno v:
International Journal of Neuropsychopharmacology
Introduction Due to the heterogeneity of psychiatric illnesses and overlapping mechanisms, patients with psychosis are differentially responsive to pharmaceutical drugs. In addition to having therapeutic effects for schizophrenia and bipolar disorder
Autor:
Troy Farncombe, Jayant Bhandari, Ritesh Daya, Joella Ho, Ram K. Mishra, Christopher D. Rowley, Sharnpreet K. Kooner, Nicholas A. Bock
Publikováno v:
Frontiers in Behavioral Neuroscience
Frontiers in Behavioral Neuroscience, Vol 12 (2018)
Frontiers in Behavioral Neuroscience, Vol 12 (2018)
PAOPA, a potent analog of Prolyl-Leucyl-Glycinamide, has shown therapeutic potential at the preclinical stage for dopaminergic related illnesses, including animal models of schizophrenia, Parkinson’s disease and haloperidol-induced extrapyramidal m
Autor:
Yuxin Tian, Sharon Thomson, Ashley Bernardo, Joella Ho, Ram K. Mishra, Bailey A. Dyck, Ritesh Daya
Publikováno v:
Synapse. 73:e22084
Schizophrenia is a mental disorder characterized by positive symptoms, negative symptoms, and cognitive dysfunction. Phencyclidine (PCP)-a N-methyl-D-aspartate (NMDA) receptor antagonist-induces symptoms indistinguishable from those of schizophrenia.
Autor:
Aue, Adam1 (AUTHOR), Ho, Joella2 (AUTHOR), Zhu, Rongbo3 (AUTHOR), Kim, Harold3,4 (AUTHOR), Jeimy, Samira3,5 (AUTHOR) Samira.Jeimy@lhsc.on.ca
Publikováno v:
Allergy, Asthma & Clinical Immunology. 7/6/2021, Vol. 17 Issue 1, p1-10. 10p.
Autor:
KANSAL, NISHA1, SAMUEL SEUNGHON KIM1
Publikováno v:
Meducator. Apr2016, Issue 29, p15-19. 5p.
Publikováno v:
International Journal of Neuropsychopharmacology; Jun2018, Vol. 21 Issue 6, p616-622, 7p